A Study of Noscapine HCl (CB3304 ) in Patients With Relapsed or Refractory Multiple Myeloma

Summary

This is a phase 1 study to evaluate the safety and determine maximum tolerated dose, safety \& tolerability of noscapine HCl in patients with advanced multiple myeloma

Timeline

Start

2007-12

Primary completion

2010-07

Completion

2010-07

Outcome

Outcome not reported

Stopped: “Terminated early due to lack of clinical response.”

Drugs

Indications